NYSE:GMED Globus Medical Q3 2026 Earnings Date & Estimates $74.69 +1.36 (+1.85%) Closing price 03:59 PM EasternExtended Trading$74.65 -0.04 (-0.05%) As of 05:31 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Globus Medical is scheduled to report Q3 2026 earnings on Thursday, November 5, 2026, after market closes. The conference call is scheduled for 4:30 PM ET. Research:ProfileEarnings HistoryForecast Upcoming Earnings Announcement QuarterQ3 2026Announcement DateNovember 5, 2026TimeAfter Market ClosesConference Call4:30 PM ET Add to CalendarGoogle Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab) What Analysts Expect from Globus Medical in Q3 2026Globus Medical is expected to post earnings of $1.20 per share on revenue of $792.28 million. In the same quarter a year earlier Globus Medical reported $1.18 per share on revenue of $769.05 million. Globus Medical last reported on August 6, 2026, posting $1.34 per share and beating the $1.10 consensus estimate. Globus Medical has beaten the consensus EPS estimate in 7 of its last 8 quarters.Consensus EstimatesConsensus EPS$1.20Expected Revenue$792.28 millionPrior-Year EPS$1.18Prior-Year Revenue$769.05 millionExpected EPS Growth+1.7%Expected Revenue Growth+3.0%Recent Track RecordLast ReportedQ2 2026Last Quarter EPS$1.34 (Beat by +$0.24)Last Quarter Revenue$789.61 millionEPS Beat Rate7 of last 8 quartersPrepare for the Q3 2026 CallEarnings HistoryCompany ProfileQ2 2026 Earnings ReportQ1 2026 Earnings ReportQ4 2025 Earnings Report Globus Medical Q3 2026 Earnings FAQ When does Globus Medical report Q3 2026 earnings? Globus Medical (NYSE:GMED) is scheduled to report Q3 2026 earnings on Thursday, November 5, 2026, after market closes. What time is Globus Medical's Q3 2026 earnings call? Globus Medical's Q3 2026 earnings conference call is scheduled for Thursday, November 5, 2026 at 4:30 PM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date. What is the consensus EPS estimate for Globus Medical? Analysts expect Globus Medical to post earnings of $1.20 per share for Q3 2026. How much revenue is Globus Medical expected to report? The consensus revenue estimate for Globus Medical is $792.28 million for Q3 2026. Globus Medical Earnings HeadlinesShould Globus Medical's Expanding Musculoskeletal Pipeline and Cash-Funded Growth Strategy Matter to GMED Investors?October 8 at 7:15 PM | finance.yahoo.comGlobus Medical (GMED) Stock Sees Modest Fair Value Cut As Analysts Split On OutlookOctober 8 at 7:15 PM | finance.yahoo.comReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and stinging losses? Dave Aquino is giving away the exact 11-hour options strategy he uses in volatile markets. You get the plain English blueprint behind the strategy and the very same "rinse and repeat" ticker he's traded nearly 900 times with a 95.3% success rate. It's so simple to understand, you could trade it tomorrow.October 9 at 1:00 AM | Base Camp Trading (Ad)Globus Medical (NYSE:GMED) versus Lifeward (NASDAQ:LFWD) Critical SurveyOctober 4, 2026 | americanbankingnews.comRBC Cuts Price Target on Globus Medical to $85 From $115, Keeps Outperform RatingOctober 1, 2026 | marketscreener.comMReviewing Globus Medical (NYSE:GMED) and CONMED (NYSE:CNMD)October 1, 2026 | americanbankingnews.comSee More Globus Medical Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Globus Medical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Globus Medical and other key companies, straight to your email. Email Address About Globus MedicalGlobus Medical (NYSE:GMED) is a medical device company that develops musculoskeletal solutions for surgeons, hospitals and ambulatory surgery centers. Its primary focus is the design, development and commercialization of products used in spinal surgery, including implants, instruments, navigation systems and robotic-assisted technologies. The company’s portfolio includes the ExcelsiusGPS robotic navigation platform, Excelsius3D imaging technology, spinal implants and systems for procedures such as deformity correction, degenerative spine treatment and minimally invasive surgery. Globus Medical also offers products for orthopedic trauma, including fixation systems and other devices used to treat fractures and support bone healing. Founded in 2003 and headquartered in Audubon, Pennsylvania, Globus Medical serves customers in the United States and international markets through direct sales and distribution channels. In 2023, the company completed its combination with NuVasive, expanding its product offerings and global presence in spine and related musculoskeletal care. Dan Scavilla serves as the company’s chief executive officer, while founder David C. Paul serves as executive chairman.View Globus Medical ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Palantir’s Rally Puts Wall Street in Catch-Up Mode Ahead of November EarningsApplied Digital’s Hidden Moat Could Unlock Massive UpsideLevi's Stock Dip Reveals Value Opportunity Despite Q3 HeadwindsTilray Finds a Path to Growth Without Waiting on U.S. Cannabis ReformPepsiCo Stock Looks Poised to Bottom With High Yield, Deep ValueMicrosoft Is Almost Back to $555—Now the Hard Part BeginsSkydance Just Became a Media Giant—With an $80 Billion Debt Load Upcoming Earnings Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026)Wells Fargo & Company (10/13/2026)Johnson & Johnson (10/13/2026)UnitedHealth Group (10/13/2026)Bank of America (10/14/2026)BlackRock (10/14/2026)Morgan Stanley (10/14/2026)Progressive (10/14/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
